PCV138 Using a Population- Based, Budget- Constrained, Cost-Effectiveness Model to Assess the Health and Economic Impacts of Using Statins for Primary Prevention Based on the Jupiter Trial intended Use Population
Abstract
Authors
R. Arbel D. Greenberg